Citigroup Inc Tg Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 168,277 shares of TGTX stock, worth $4.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,277

Previous 74,547 125.73%

Holding current value

$4.71 Million

Previous $1.33 Million 196.76%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$17.21 - $25.28 $1.61 Million - $2.37 Million	93,730 Added 125.73%	168,277 $3.94 Million
Q2 2024 Aug 12, 2024	SELL	$13.32 - $19.19 $6.05 Million - $8.71 Million	-454,022 Reduced 85.9%	74,547 $1.33 Million
Q1 2024 May 10, 2024	BUY	$13.02 - $21.3 $2.13 Million - $3.48 Million	163,225 Added 44.68%	528,569 $8.04 Million
Q4 2023 Feb 09, 2024	SELL	$6.68 - $18.81 $454,193 - $1.28 Million	-67,993 Reduced 15.69%	365,344 $6.24 Million
Q3 2023 Nov 09, 2023	BUY	$8.36 - $26.5 $1.95 Million - $6.19 Million	233,650 Added 117.01%	433,337 $3.62 Million
Q2 2023 Aug 10, 2023	SELL	$15.48 - $35.0 $3.93 Million - $8.88 Million	-253,615 Reduced 55.95%	199,687 $4.96 Million
Q1 2023 May 11, 2023	BUY	$10.23 - $19.34 $228,650 - $432,268	22,351 Added 5.19%	453,302 $6.82 Million
Q4 2022 Feb 09, 2023	SELL	$5.01 - $11.83 $3.21 Million - $7.57 Million	-640,001 Reduced 59.76%	430,951 $5.1 Million
Q3 2022 Nov 10, 2022	BUY	$4.57 - $8.4 $1.35 Million - $2.47 Million	294,444 Added 37.92%	1,070,952 $6.34 Million
Q2 2022 Aug 10, 2022	BUY	$3.74 - $10.66 $2.52 Million - $7.2 Million	675,007 Added 665.02%	776,508 $3.3 Million
Q1 2022 May 12, 2022	SELL	$7.81 - $20.45 $3.2 Million - $8.39 Million	-410,320 Reduced 80.17%	101,501 $966,000
Q4 2021 Feb 10, 2022	BUY	$15.2 - $35.51 $6.54 Million - $15.3 Million	430,157 Added 526.74%	511,821 $9.73 Million
Q3 2021 Nov 10, 2021	BUY	$21.78 - $40.45 $1.78 Million - $3.3 Million	81,664 New	81,664 $2.72 Million

Others Institutions Holding TGTX

# of Institutions

337

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.07B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account